Open AccessComparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naïve patients with chronic hepatitis B: a multicenter real-life study
Author(s) -
Ayşe Batırel,
Ertuğrul Güçlü,
Ferhat Arslan,
Funda Koçak,
Oğuz Karabay,
Serdar Özer,
Münevver Turanlı,
Ali Mert
Publication year - 2014
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2014.09.004
Subject(s) - entecavir , medicine , hbsag , gastroenterology , hbeag , hepatitis b , seroconversion , hepatocellular carcinoma , chronic hepatitis , decompensation , serology , hepatitis b virus , immunology , antibody , virus , lamivudine
To compare responses to tenofovir (TDF) and entecavir (ETV) therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom